Literature DB >> 19399735

A single-center experience of 500 liver transplants using the modified piggyback technique by Belghiti.

Arianeb Mehrabi1, Zhoobin A Mood, Hamidreza Fonouni, Arash Kashfi, Norbert Hillebrand, Sascha A Müller, Jens Encke, Markus W Büchler, Jan Schmidt.   

Abstract

Over the past 4 decades, the surgical techniques of liver transplantation (LTx) have permanently evolved and been modified. Among these, the modified piggyback (MPB) technique by Belghiti offers specific advantages. The objective of this study was to present our single-center experience with the MPB technique in 500 cases. Recipients' perioperative data were prospectively collected and evaluated. Postoperative and specific complications, stay in the intensive and intermediate care unit, and the mortality rate with cause of death were analyzed. Most recipients were classified as Child C (49.1%). For the patients who underwent LTx for the first time, alcoholic (23.9%) and viral (22.2%) cirrhosis and hepatocellular carcinoma (15.1%) were the prevalent indications. The overall median warm ischemia time, anastomosis duration, and operative time were 45, 108, and 320 minutes, respectively. The median intraoperative blood loss was 1500 mL. A venovenous bypass was never needed to maintain hemodynamic stability. Only in a few cases was temporary inferior vena cava clamping necessary. Most prominent surgical complications were hemorrhage, hematoma, and wound dehiscence. Renal failure occurred in 6.2% of patients. The overall median stay in the intensive and intermediate care unit was 14 days. The mortality rates within 30 and 90 days were 6.3% and 13.3%, respectively. No technique-related death occurred. The MPB technique by Belghiti is a feasible and simple LTx technique. The caval flow is preserved during the anhepatic phase, and this minimizes the need for venovenous bypass or portocaval shunt. This technique requires only 1 caval anastomosis, which is easy to perform with a short anhepatic phase. To minimize the risk of outflow obstruction, attention should be paid by doing a wide cavocavostomy cranially to the donor inferior vena cava in a door-lock manner. This technique can be applied in almost all patients undergoing LTx for the first time and liver retransplantation as well.

Entities:  

Mesh:

Year:  2009        PMID: 19399735     DOI: 10.1002/lt.21705

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  17 in total

1.  Technical Aspects of Orthotopic Liver Transplantation-a Survey-Based Study Within the Eurotransplant, Swisstransplant, Scandiatransplant, and British Transplantation Society Networks.

Authors:  Zoltan Czigany; Marcus N Scherer; Johann Pratschke; Markus Guba; Silvio Nadalin; Arianeb Mehrabi; Gabriela Berlakovich; Xavier Rogiers; Jacques Pirenne; Jan Lerut; Zoltan Mathe; Philipp Dutkowski; Bo-Göran Ericzon; Massimo Malagó; Nigel Heaton; Wenzel Schöning; Jan Bednarsch; Ulf Peter Neumann; Georg Lurje
Journal:  J Gastrointest Surg       Date:  2018-08-10       Impact factor: 3.452

2.  An alternative surgical technique for caval preservation in liver transplantation.

Authors:  Cataldo Doria; Adam S Bodzin; Adam M Frank; Warren R Maley; Carlo B Ramirez
Journal:  J Gastrointest Surg       Date:  2010-04-13       Impact factor: 3.452

3.  Results of a newborn liver transplant program in the era of piggyback technique and extended donor criteria in Italy.

Authors:  Giuseppe Maria Ettorre; Roberto Santoro; Giovanni Vennarecci; Pasquale Lepiane; Mario Antonini; Eugenio Santoro
Journal:  Updates Surg       Date:  2011-07-19

4.  Diagnosis, treatment and outcome of hepatic venous outflow obstruction in paediatric liver transplantation: 24-year experience at a single centre.

Authors:  Alexis Galloux; Erika Pace; Stephanie Franchi-Abella; Sophie Branchereau; Emmanuel Gonzales; Daniele Pariente
Journal:  Pediatr Radiol       Date:  2018-02-21

5.  Upregulation of TLR2/4 expression in mononuclear cells in postoperative systemic inflammatory response syndrome after liver transplantation.

Authors:  Ziqing Hei; Xinjin Chi; Nan Cheng; Gangjian Luo; Shangrong Li
Journal:  Mediators Inflamm       Date:  2010-06-16       Impact factor: 4.711

6.  Risk factors for early viral infections after liver transplantation.

Authors:  Cornelius Johannes Busch; Benedikt Hermann Siegler; Heike Werle; Christoph Lichtenstern; Thomas Bruckner; Alexandra Heininger; Arianeb Mehrabi; Karl Heinz Weiss; Markus Alexander Weigand; Marcel Hochreiter
Journal:  Langenbecks Arch Surg       Date:  2018-04-25       Impact factor: 3.445

7.  The impact of major extended donor criteria on graft failure and patient mortality after liver transplantation.

Authors:  Vladimir J Lozanovski; Elias Khajeh; Hamidreza Fonouni; Jan Pfeiffenberger; Rebecca von Haken; Thorsten Brenner; Markus Mieth; Peter Schirmacher; Christoph W Michalski; Karl Heinz Weiss; Markus W Büchler; Arianeb Mehrabi
Journal:  Langenbecks Arch Surg       Date:  2018-08-15       Impact factor: 2.895

8.  Bypass during Liver Transplantation: Anachronism or Revival? Liver Transplantation Using a Combined Venovenous/Portal Venous Bypass-Experiences with 163 Liver Transplants in a Newly Established Liver Transplantation Program.

Authors:  Anne Mossdorf; Florian Ulmer; Karsten Junge; Christoph Heidenhain; Marc Hein; Ilknur Temizel; Ulf Peter Neumann; Wenzel Schöning; Maximilian Schmeding
Journal:  Gastroenterol Res Pract       Date:  2015-03-02       Impact factor: 2.260

9.  Cavo-caval intervention stent insertion after deceased-donor liver transplantation using side-to-side piggyback technique: report of a case.

Authors:  In-Gyu Kim; Byung Seup Kim; Jang Yong Jeon; Jae Woo Kwon; Joo Seop Kim; Doo Jin Kim; Jae Pil Jung; Seong Eun Chon; Han Joon Kim; Eui Yong Jeon; Min-Jeong Kim; Kwanseop Lee
Journal:  Korean J Hepatobiliary Pancreat Surg       Date:  2011-08-31

10.  Prospective Randomized Trial Comparing Hepatic Venous Outflow and Renal Function after Conventional versus Piggyback Liver Transplantation.

Authors:  Marília D'Elboux Guimarães Brescia; Paulo Celso Bosco Massarollo; Ernesto Sasaki Imakuma; Sérgio Mies
Journal:  PLoS One       Date:  2015-06-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.